BAY 1238097
CAS No. 1564268-08-1
BAY 1238097 ( BAY1238097 )
Catalog No. M12230 CAS No. 1564268-08-1
BAY 1238097 is a novel BET bromodomain inhibitor with IC50 of 50 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 710 | Get Quote |
|
100MG | 1224 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBAY 1238097
-
NoteResearch use only, not for human use.
-
Brief DescriptionBAY 1238097 is a novel BET bromodomain inhibitor with IC50 of 50 nM.
-
DescriptionBAY 1238097 is a novel BET bromodomain inhibitor with IC50 of 50 nM, inhibits the interaction between BRD4, BRD3 or BRD2 and H4 with IC50 values of 63 nM, 609 nM and 2430 nM in the NanoBRET assay; shows selectivity of the compound for BRD4; strongly reduces c-Myc transcript and protein levels in MOLM-13 (AML) and MOLP-8 (MM) cell lines; exhibits strong efficacy in the AML models THP-1, MOLM-13 and KG-1.
-
SynonymsBAY1238097
-
PathwayChromatin/Epigenetic
-
TargetBromodomain
-
RecptorBromodomain
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1564268-08-1
-
Formula Weight451.57
-
Molecular FormulaC25H33N5O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : 150 mg/mL 332.18 mM
-
SMILESO=C(N1N=C(C2=CC=C(N3CCN(C)CC3)C=C2)C4=CC(OC)=C(OC)C=C4C[C@@H]1C)NC
-
Chemical Name(S)-7,8-dimethoxy-N,4-dimethyl-1-(4-(4-methylpiperazin-1-yl)phenyl)-4,5-dihydro-3H-benzo[d][1,2]diazepine-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bernasconi E, et al. Br J Haematol. 2017 Jun 27. doi: 10.1111/bjh.14803.
2. Patent WO2014026997A1.
2. Patent WO2014026997A1.
molnova catalog
related products
-
BAY-850
BAY-850 (BAY 850, BAY850) is a potent, isoform selective, cellularly active ATAD2 bromodomain inhibitor with binding IC50 of 166 nM in TR-FRET assay.
-
biBET
biBET is a potent, selective, bivalent inhibitor of BET bromodomains.
-
GNE-207
GNE-207 (GNE207) is a novel potent, selective, orally active CBP/p300 bromodomain with IC50 of 1.0 nM.